LACY BOYD: Open Payments
NPI 1194951418 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 59 payments from 13 companies in 2025. Trend: 2023 $893 · 2024 $720 · 2025 $1,170
Food & beverage: $1,101Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $327 |
| Novartis Pharmaceuticals Corporation | 12 | $249 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $154 |
| UCB, Inc. | 4 | $93 |
| LEO Pharma Inc. | 3 | $65 |
| Organon LLC | 5 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Amgen Inc. | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $31 |
| Incyte Corporation | 1 | $26 |
Products named: TREMFYA, COSENTYX, Bimzelx, Rhapsido, ILUMYA, DUPIXENT, Odomzo, ANZUPGO.
Industry payments across KY — which companies pay providers there.
